Chronic pain affects approximately 50 million Americans, and this therapy avoids addiction risks linked to narcotic treatments. Researchers mapped brain cells that act as pain trackers and used AI to create a targeted gene therapy that provides pain relief without affecting normal sensation.

The study involved teams from the University of Pennsylvania Perelman School of Medicine, School of Nursing, Carnegie Mellon and Stanford University.









